测量与药物和堕胎相关的出血:一个系统的范围审查
Alice F Cartwright1, Rubina Hussain1, Clyde Schwab1
1Guttmacher Institute, New York, NY.
Contraception
|March 10, 2026
概括
药物流产 (MA) 出血通常以持续时间和体积来衡量,但患者的观点代表性不足. 未来的研究应该为MA出血经历制定以患者为中心的措施.
科学领域:
- 生殖健康 生殖健康
- 患者报告的结果
- 医学堕胎研究 医学堕胎研究
背景情况:
- 流血是药物流产 (MA) 的预期结果.
- 患者对出血的期望和经历显著影响了他们的整体堕胎经历.
- 了解如何测量MA相关出血对于改善患者护理和研究至关重要.
研究的目的:
- 系统地审查和记录现有文献中的药物流产相关出血的测量方法.
- 从患者的角度分析这些方法,确定差距和需要改进的领域.
主要方法:
- 对2000年1月至2025年3月期间发表的同行评审研究进行了系统范围审查.
- 通过PubMed确定了研究,并根据预定义的标准对其进行了包含选.
- 数据提取侧重于定量,质量和混合方法研究,涵盖出血发作,持续时间,体积,患者期望和可接受性.
主要成果:
- 在包括的111项研究中,最常测量的是出血持续时间 (89) 和体积 (65).
- 患者日记,日志,问卷和采访是常见的数据收集方法.
- 没有报告使用患者参与过程中开发的测量工具的研究.
结论:
- 目前的文献提供了与MA相关的出血测量的多样化概述,重点是持续时间和体积.
- 需要开发患者报告的结果指标,包括更广泛的患者体验.
- 来自月经健康研究的见解可以为创建更多以患者为中心的MA相关出血测量工具提供信息.
更多相关视频
03:01Author Spotlight: A Reproductive Hysteroscopy Approach for Complete Endometrial Polyp Removal and Enhanced Endometrial Receptivity
Published on: August 2, 2024
2.3K
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
10.2K
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
518
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
518
Intrauterine Drug Delivery Systems
74
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
74
